🔎 Trials Near Me

Home › Ovarian Cancer › Virginia › Norfolk

Ovarian Cancer clinical trials in Norfolk, VA

7 studies for Ovarian Cancer are looking for participants at sites in and around Norfolk (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

The Vanguard Study: Testing a New Way to Screen for Cancer

RecruitingHealthy volunteers welcome
  • Sentara Norfolk General Hospital, Norfolk
Ages 45 to 75 · All sexes · Updated Oct 5, 2026 · NCT06995898

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

RecruitingPhase 3
  • Virginia Oncology Associates (VOA) ( Site 8013), Norfolk
Ages 18 and older · Women · Updated Sep 17, 2026 · NCT07318558

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

RecruitingPhase 1/2
  • USOR Virginia Oncology Associates, Norfolk
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT05579366

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

RecruitingPhase 2
  • 300, Norfolk
Ages 18 and older · Women · Updated Jul 16, 2026 · NCT06906341

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

RecruitingPhase 3
  • Virginia Oncology Associates, Norfolk
Ages 18 and older · Women · Updated Apr 16, 2026 · NCT05659381

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

RecruitingPhase 2
  • SCRI - Virginia Oncology Associates, Norfolk
Ages 18 and older · Women · Updated Dec 23, 2025 · NCT06690775

About Ovarian Cancer

Ovarian cancer is a cancerous tumor that forms in the tissues of an ovary. The ovaries are a pair of female reproductive glands that make eggs and female hormones.

More about Ovarian Cancer on MedlinePlus

Ovarian Cancer trials in other cities

Other studies in Norfolk

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.